Evidence check: VKORC1 in the context of weight loss

VKORC1 encodes vitamin K epoxide reductase complex subunit 1, a key enzyme in vitamin K recycling and a primary target of warfarin. There is no credible scientific evidence linking VKORC1 variants to weight loss, metabolic rate, or body composition. Its well-established role is in pharmacogenetics: variants affect warfarin sensitivity and dosing. Any claim that VKORC1 testing aids weight management is not supported by human studies and likely stems from marketing overreach. DNA tests for weight loss should focus on genes with moderate evidence like FTO, MC4R, or PPARG, but even these have limited predictive power. Consumers should be cautious: VKORC1 testing is only clinically indicated for anticoagulant therapy. For weight loss, evidence-based strategies (diet, exercise, behavior) remain far more impactful than single-gene tests.